KBC Group NV lowered its holdings in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 77.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,760 shares of the company’s stock after selling 12,906 shares during the quarter. KBC Group NV’s holdings in Molina Healthcare were worth $501,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of MOH. AQR Capital Management LLC increased its stake in Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after purchasing an additional 2,008,458 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in shares of Molina Healthcare by 10.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock worth $376,831,000 after purchasing an additional 201,772 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Molina Healthcare by 24.2% in the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after purchasing an additional 329,679 shares during the last quarter. Victory Capital Management Inc. increased its stake in Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after buying an additional 447,078 shares during the period. Finally, 8 Knots Management LLC purchased a new position in Molina Healthcare in the 4th quarter worth about $198,942,000. Institutional investors own 98.50% of the company’s stock.
Key Headlines Impacting Molina Healthcare
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Molina Healthcare beat Q2 earnings expectations with EPS of $1.51, and lower operating expenses helped offset weaker premium revenue and softer investment income. The company also raised its 2026 EPS outlook, which supports the long-term earnings case. Article Title
- Positive Sentiment: Analysts still see some upside from current levels despite recent weakness, with Truist and RBC both saying the stock could rise into the low-to-mid $200s. Article Title
- Neutral Sentiment: Wall Street’s consensus recommendation remains “Hold,” suggesting analysts are not turning bullish yet, but are also not broadly negative on the name. Article Title
- Negative Sentiment: Revenue and membership trends remain a concern, and multiple reports said investors were disappointed by weaker premium revenue and softer guidance even after the earnings beat. Article Title
- Negative Sentiment: Market reaction has been negative because Molina warned about a smaller Obamacare footprint and ongoing pressure in its Medicaid/ACA businesses, which outweighed the earnings beat. Article Title
Insider Buying and Selling
Molina Healthcare Stock Down 1.3%
NYSE:MOH opened at $197.64 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.63. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The company has a 50-day moving average of $206.19 and a 200 day moving average of $177.02. The firm has a market cap of $10.30 billion, a PE ratio of -1,097.94 and a beta of 0.74.
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The business had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter last year, the firm posted $5.48 EPS. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. As a group, research analysts anticipate that Molina Healthcare, Inc will post 5.31 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities research analysts have issued reports on MOH shares. Barclays lowered their price objective on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a research report on Friday. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Molina Healthcare in a research report on Friday. Truist Financial decreased their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a research note on Friday. Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Jefferies Financial Group set a $230.00 price objective on Molina Healthcare in a report on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $203.38.
Read Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading
- Five stocks we like better than Molina Healthcare
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
